Samuel Aparicio
@sajraparicio
physician scientist working in genomics, cancer therapeutics, single cell evolution, sailing and skiing addict. Opinions are my own.
ID: 565843376
https://aparicio.molonc.ca 29-04-2012 00:14:37
482 Tweet
1,1K Followers
316 Following
How do the #genome, #epigenome and #transcriptome co-evolve in colorectal #cancer? In the second of two papers in @nature, we find gene expr is not strongly heritable & evaluate "driverness" of muts directly in patient tumours nature.com/articles/s4158… Andrea Sottoriva #EPICC2 1/7
Fantastic to see the elegant work of colleagues Trevor Graham and Andrea Sottoriva and their labs unpicking the fundamental mechanisms of fitness in cancer encoded by the epigenome and mutations in colorectal cancer. doi.org/10.1038/s41586… and doi.org/10.1038/s41586…
Spatial transcriptomics meets complex analysis – our new method Belayer models spatial gene expression in layered tissues, now published in Cell Systems. Work led by Cong Ma and Uthsav Chitra with Shirley Zhang. 1/6 authors.elsevier.com/a/1fxla8YyDfj7…
🎉🎉🎉Carlos will receive this year's Fondation ARC Leopold Griffuel Award, the most important prize in #CancerResearch in Europe! Amazing recognition of the contributions from all members of the lab and patients over the past 26 years! 🥹🥰 #bcsm Cancer Research UK CRUK Cambridge Institute Cambridge University
Hearing fantastic science arising from the enormous influence of Simon Tavaré in cancer biology Columbia - Irving Institute for Cancer Dynamics
The lab is hiring, space for a postdoctoral fellow in an exciting new drug development field, G4-quadruplex biology and cancer. Our team is multidisciplinary and recently funded to work on the mechanisms of G4 biology and the non-coding genome in cancer. ubc.wd10.myworkdayjobs.com/en-US/ubcfacul…
Benefits of science in Vancouver … lab social afternoons at the beach to discuss science and life. Join us! University of British Columbia BC Cancer BC Cancer Foundation
Seminal advance from the Dan Landau pioneering WGS plasma assays for residual disease detection. Proud to have contributed to this pioneering translational genomics approach to patient management.